{"result": {"id": "8d6f20f7-66c2-48a3-9317-582129e29c2d", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>OSAS<|>EVENT<|>Obstructive Sleep Apnea Syndrome (OSAS) is a sleep disorder characterized by repeated episodes of upper airway obstruction during sleep, leading to reduced airflow and oxygen levels. Treatment options include lifestyle changes, PAP therapy, and surgical interventions.\")\n##\n(\"entity\"<|>PAP<|>ORGANIZATION<|>Positive Airway Pressure (PAP) therapy is a treatment for OSAS that includes CPAP, APAP, and BiPAP. It is recommended for moderate to severe OSAS patients, especially those with daytime sleepiness or comorbid conditions like hypertension.\")\n##\n(\"entity\"<|>CPAP<|>ORGANIZATION<|>Continuous Positive Airway Pressure (CPAP) is a type of PAP therapy used to treat OSAS by providing a constant stream of air to keep the airways open during sleep.\")\n##\n(\"entity\"<|>APAP<|>ORGANIZATION<|>Automatic Positive Airway Pressure (APAP) is a type of PAP therapy that adjusts air pressure dynamically based on the patient's breathing patterns.\")\n##\n(\"entity\"<|>BIPAP<|>ORGANIZATION<|>Bilevel Positive Airway Pressure (BiPAP) is a type of PAP therapy that provides two levels of air pressure: higher during inhalation and lower during exhalation.\")\n##\n(\"entity\"<|>MAD<|>ORGANIZATION<|>Mandibular Advancement Device (MAD) is an oral appliance used to treat mild to moderate OSAS by advancing the lower jaw to keep the airway open.\")\n##\n(\"entity\"<|>ASV<|>ORGANIZATION<|>Adaptive Servo-Ventilation (ASV) is a type of PAP therapy that adjusts pressure support based on the patient's breathing patterns, often used for complex sleep apnea.\")\n##\n(\"relationship\"<|>OSAS<|>PAP<|>PAP therapy is a primary treatment for OSAS, including CPAP, APAP, and BiPAP.<|>8)\n##\n(\"relationship\"<|>OSAS<|>CPAP<|>CPAP is a specific type of PAP therapy used to treat OSAS.<|>8)\n##\n(\"relationship\"<|>OSAS<|>APAP<|>APAP is a specific type of PAP therapy used to treat OSAS.<|>8)\n##\n(\"relationship\"<|>OSAS<|>BIPAP<|>BiPAP is a specific type of PAP therapy used to treat OSAS.<|>8)\n##\n(\"relationship\"<|>OSAS<|>MAD<|>MAD is an alternative treatment for mild to moderate OSAS or for patients who cannot tolerate PAP therapy.<|>6)\n##\n(\"relationship\"<|>OSAS<|>ASV<|>ASV is a specialized PAP therapy used for complex sleep apnea, including certain cases of OSAS.<|>6)\n##\n(\"relationship\"<|>CPAP<|>PAP<|>CPAP is a subtype of PAP therapy.<|>9)\n##\n(\"relationship\"<|>APAP<|>PAP<|>APAP is a subtype of PAP therapy.<|>9)\n##\n(\"relationship\"<|>BIPAP<|>PAP<|>BiPAP is a subtype of PAP therapy.<|>9)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558773, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 725, "prompt_tokens": 2480, "total_tokens": 3205, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 688}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 或轻度 OSAS患者以及扁  桃体 Ⅱ度及以上肥大的重度 OSAS患者 。⑤采用气  道正压通气(positive airway pressure,PAP) 治疗 ,包  括 CPAP、全自动 气 道 正 压 通 气 (automatic positive airway pressure,APAP) 和双水平气道正压通气(bi- levelpositive airway pressure,BiPAP) 治疗[688]  :对中  重度 OSAS,尤其是有白天过度嗜睡、睡眠相关生活质  量降低和/或合并高血压的患者 ; 轻度 OSAS但症状  明显 ,或合并心脑血管疾病、糖尿病 。其降压效果较平  稳(2~4 mmHg) ,但对心血管疾病的疗效不确切 , 主  要取决于患者对治疗的依从性 。⑥舌下神经电刺激上  气道治疗 OSAS是一种有前景的方法 ,但其对血压的  影响尚不清楚[698] 。OSAS的治疗方案推荐见表 28。\n　10.4  药物相关性高血压  药物相关性高血压是指常 规剂量的药物本身或该药物与其他药物之间发生相互 作用而引起血压升高 , 当血压 >140/90mmHg时即 考虑药物性高血压 。可引起血压升高的药物主要包括 非甾体类抗炎药、抗组胺类药物、甲状腺激素、抗抑郁\n\n\n\n药、口 服 避 孕 药 和 抗 肿 瘤 药、儿 茶 酚 胺 类 药 物 等[700-701] 。其分类、主要常见药物、简单机制和处理原\n\n\n则见表 29。\n\n\n表 28   OSAS的治疗方案推荐\n\n方案\t治疗方式\t推荐人群\n改善生活方式\t减重\n适当体育锻炼\n避免饮酒和服用镇静药物 吸气肌肉力量训练\t　肥胖患者 所有患者 所有患者\n单纯鼾症、轻中度 OSAS或不耐受 MAD或 CPAP的重度 OSAS;与其 他疗法配合治疗\n仪器治疗\t①PAP治疗 :包括 CPAP、autoCPAP、BiPAP、autoBiPAP, 自适应伺服通气(ASV)[698]\n\n②体位治疗仪\n③下颌前移装置(口腔矫治器 ,MAD)\n\n④舌下神经电刺激[699]\t　中重度 OSAS;轻度 OSAS但症状明显 , 或合并心脑血管疾病、糖尿 病 ;OSAS的围 手 术 期 治 疗 ; 经 手 术 或 其 他 疗 法 治 疗 后 依 然 存 在 OSAS;OSAS与 COPD共存的重叠综合征\n体位相关 OSAS患者\n单纯鼾症和轻中度 OSAS;不耐受 CPAP的重度 OSAS;与手术或无创 正压通气联合治疗重度 OSAS\n中重度 OSAS或 PAP无效及不耐受者\n外科手术\t上气道手术 减重手术\t非严重肥胖的中度或轻度 OSAS;扁桃体Ⅱ度及以上肥大的重度 OSAS 有合并症的严重肥胖患者\n　　注 :OSAS为阻塞性睡眠呼�\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_280bdab2dff2901525a61c16a90f3a39effc95177fd495a243719a3eb1517679_v2"}